Press Release Summary: Over the past 20 years, prevention of recurrent vaginal yeast infections is made by administering daily doses of the antifungal ketoconazole. While it is effective, ketoconazole can cause serious side effects, which include jaundice. Doctors tried a newer antifungal medication and a weekly dose of Diflucan proved to be well tolerated and effective in preventing recurrent vaginal yeast infections.
Press Release Body: United States, New York, New York, May 15, 2008 - DrugStoreTM.Com offers something fresh to provide you, Weekly Antifungal Dose Tames Vaginal Yeast Infections
Why DrugStoreTM offer Weekly Antifungal Dose? Because according to a study in The New England Journal of Medicine, recurrent vaginal yeast infections can be reduced by a weekly dose of an antifungal medication such as Diflucan.
What can we expect from Diflucan Antifungal? Vulvovaginal candidasis is a vaginal yeast infection which may not be life-threatening but can cause discomfort, even painful, nuisance that women would rather not talk about. About 5% to 8% of women acquire recurrent vaginal candida infections. This condition is not considered a sexually transmitted disease, and the majority of patients have no recognizable risk factors.
A little history about vaginal yeast infections Over the past 20 years, prevention of recurrent vaginal yeast infections is made by administering daily doses of the antifungal ketoconazole. While it is effective, ketoconazole can cause serious side effects, which include jaundice. In finding a safe and effective therapy to keep symptoms at bay, doctors were challenged to try a newer anti-fungal medication. Weekly doses of Diflucan proved to be well tolerated and effective in preventing recurrent vaginal yeast infections. Dr. Jack Sobel, a professor of internal medicine and chief of infectious disease unit at Wayne State University School of Medicine, and his colleagues evaluated the effectiveness of weekly oral Diflucan therapy in women with a history of recurrent vaginal yeast infections. The research study involved 387 women who received either Diflucan or a placebo weekly for six months. This was followed by six months of observation without therapy.
The study showed that 90% of the patients who received Diflucan remained free of yeast infections during the first six-month period, compared with about 36% of those who took a placebo.
Nine months after the start of the study 73% of the women who took Diflucan remained free of yeast infections, compared with about 28% of the women not taking the anti-fungal medication. After one year, about twice as many women taking Diflucan were still free of infection compared with those on the placebo.
The researchers noted on the journal that while a long-term weekly treatment with Diflucan may reduce the rate of recurrence of symptomatic vulvovaginal candidasis, a long-term cure, however, remains difficult to achieve.
If you would like to know more information about health, wellness, and pharmacy solutions, log on to www.drugstoretm.com or call: 1-646-278-1136, Monday to Friday, 9:00am to 9:00pm (Pacific Standard Time).
To have more idea on our new product offer please visit us at http://www.drugstoretm.com/products/buy/diflucan
Web Site: http://www.drugstoretm.com/products/buy/diflucan
Contact Details: Summer Montgomery 2330 Avenue of the Americas New York, NY 10020 USA Phone: (212) 595-2132 summer.montogomery@gmail.com http://www.drugstoretm.com
2025
